Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent

NCT02255864 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease
Myocardial Ischemia

Interventions

DEVICE: AmM FORTITUDE Bioresorbable Drug-Eluting Coronary Scaffold

Sponsor

Amaranth Medical Inc.